The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bashankaev B.N.

European Medical Centre. Moscow, Russia

Wexner S.D.

Cleveland Clinic Florida, Department of Colorectal Surgery, Weston, FL, USA

Arkharov A.V.

Chair of Surgery of Sechenov First Moscow State Medical University of Healthcare Ministry of the Russian Federation, Moscow, Russia, City Clinical Hospital No. 3, Moscow, Russia

Common sense of diosmin administration in combined treatment of hemorrhoids

Authors:

Bashankaev B.N., Wexner S.D., Arkharov A.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2018;(8): 83‑89

DOI: 10.17116/hirurgia201808283

Views: 11153

Downloaded: 156

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Bashankaev BN, Wexner SD, Arkharov AV. Common sense of diosmin administration in combined treatment of hemorrhoids. Pirogov Russian Journal of Surgery. 2018;(8):83‑89. (In Russ.)
https://doi.org/10.17116/hirurgia201808283

Подписка 2025 (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Close metadata
Recommended articles:
The effe­ctiveness of flavonoids in the postoperative treatment of patients with hemo­rrhoids. Piro­gov Russian Journal of Surgery. 2024;(9):52-56
Hesperidin: Pote­ntial but Unde­restimated Oppo­rtunities. Journal of Venous Diso­rders. 2023;(4):352-360

Flavonoids are herbal medicines and widely used for chronic venous diseases and hemorrhoids. Flavonoid diosmin in both micronized and non-micronized form is a part of various drugs. According to literature data, flavonoids are able to reduce venous stasis, suppress local inflammation, improve venous tone and lymphatic outflow. It should be noted that biological models of in vivo trials have certain limitations while available data of different researches are contradictory. However, flavonoids were recommended for hemorrhoids in view of meta-analysis of 14 trials comparing flavonoids (diosmin, micronized purified flavonoid fraction and rutosides) with placebo in 1514 patients with hemorrhoids and Cochrane review of 24 randomized controlled trials (2,334 participants). These drugs should be administered as a part of complex therapy. At the same time, there is no conclusive evidence to prefer only one of these medicines. There are also no data confirming the benefits of daily dosage of 3000 mg per day of micronized fraction of flavonoids compared with 1800 mg of purified diosmin per day for treatment of acute hemorrhoids.

Keywords:

combined treatment of hemorrhoids
diosmin
flavonoids

Authors:

Bashankaev B.N.

European Medical Centre. Moscow, Russia

Wexner S.D.

Cleveland Clinic Florida, Department of Colorectal Surgery, Weston, FL, USA

Arkharov A.V.

Chair of Surgery of Sechenov First Moscow State Medical University of Healthcare Ministry of the Russian Federation, Moscow, Russia, City Clinical Hospital No. 3, Moscow, Russia

List of references:

  1. Nasseri YY, et al. Abnormalities in collagen composition may contribute to the pathogenesis of hemorrhoids: morphometric analysis. Tech Coloproctol. 2015;19(2):83-87.
  2. Lohsiriwat V. Hemorrhoids: from basic pathophysiology to clinical management. World J Gastroenterol. 2012;18(17):2009-2017.
  3. Willis S, et al. Haemorrhoids — a collagen disease? Colorectal Dis. 2010;12(12):1249-1253.
  4. Cuoco JA, et al. Linking Brain Arteriovenous Malformations With Anorectal Hemorrhoids: A Clinical and Anatomical Review. Anat Rec (Hoboken). 2017;300(11):1973-1980.
  5. Rubbini M, Ascanelli S and Fabbian F. Hemorrhoidal disease: is it time for a new classification? Int J Colorectal Dis. 2018;33(6):831-833.
  6. Shelygin YuA. i soavt. Klinicheskie rekomendatsii po diagnostike i lecheniyu vzroslykh patsientov s ostrym i khronicheskim gemorroem: Klinicheskie rekomendatsii. Koloproktologiya. Pod red. Yu.A. Shelygina. M.: GEOTAR-Media; 2015:30-52.
  7. Sandler RS and Peery AF. Rethinking What We Know About Hemorrhoids. Clin Gastroenterol Hepatol; 2018.
  8. Ganz RA. The evaluation and treatment of hemorrhoids: a guide for the gastroenterologist. Clin Gastroenterol Hepatol. 2013;11(6):593-603.
  9. Shelygin Y, et al. Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in pati- ents suffering acute hemorrhoidal disease. Curr Med Res Opin. 2016;32(11):1821-1826.
  10. Hain JM. Medical Treatment of Hemorrhoids Using Flavonoids. Practical Gastroenterology. 2011(March):1-5.
  11. Blagodarnyi L.A. Kombinirovannaya farmakoterapiya - zalog uspeshnogo lecheniya ostrogo i khronicheskogo gemorroya. Consilium Medicum. Khirurgiya. 2014(2):68-72.
  12. Bartnik M and Facey PC. Chapter 8 - Glycosides A2 - Badal, Simone, in Pharmacognosy, R. Delgoda, Editor. Boston: Academic Press; 2017:101-161.
  13. Molina-Calle M, Priego-Capote F and Luque de Castro MD. Development and application of a quantitative method for determination of flavonoids in orange peel: Influence of sample pretreatment on composition. Talanta. 2015;144:349-55.
  14. Del Rı́o JA, et al. Citrus limon: a source of flavonoids of pharmaceutical interest. Food Chemistry. 2004;84(3):457-461.
  15. Vandercook CE and Tisserat B. Flavonoid changes in developing lemons grown in vivo and in vitro. Phytochemistry. 1989;28(3):799-803.
  16. Atanassova M and Christova-Bagdassarian V. Rutin content in plant products. 2009;44:201-203.
  17. Rutin. [cited 2018 06.2018]; Available from: https://en.wikipedia.org/wiki/Rutin
  18. Metabolisms, E.o.c.i.f.P.-m. CYP2C9. [cited 2018; Available from: https://www.fda.gov/drugs/developmentapprovalprocess/developmentresources/druginteractionslabeling/ucm093664.htm
  19. Burkina V, et al. In vitro effects of the citrus flavonoids diosmin, naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish. Biochem Pharmacol. 2016;110-111:109-116.
  20. Farnsworth NR, et al. Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965-981.
  21. Besse J-P, Kausch-Barreto C and Garric J. Exposure Assessment of Pharmaceuticals and Their Metabolites in the Aquatic Environment: Application to the French Situation and Preliminary Prioritization. Human and Ecological Risk Assessment: An International Journal. 2008;14(4):665-695.
  22. Approved Marketing Authorisations (MA) containing DIOSMIN in Europe. [cited 2018; Available from: https://www.pharmacompass.com/active-pharmaceutical-ingredients/diosmin.
  23. Alonso-Coello P, et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg. 2006;93(8):909-920.
  24. Manthey JA, Grohmann K and Guthrie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem. 2001;8(2):135-153.
  25. Thanapongsathorn W and Vajrabukka T. Clinical trial of oral diosmin (Daflon) in the treatment of hemorrhoids. Dis Colon Rectum. 1992;35(11):1085-1088.
  26. Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology. 1994;45(6.Pt 2):566-573.
  27. Meyer OC. Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease. Angiology. 1994;45(6 Pt 2):579-584.
  28. Davis BR, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids. Dis Colon Rectum. 2018;61(3):284-292.
  29. Alonso-Coello P, et al. Laxatives for the treatment of hemorrhoids. Cochrane Database Syst Rev. 2005(4). CD004649.
  30. Perera N, et al. Phlebotonics for haemorrhoids. Cochrane Database. Syst Rev. 2012(8). CD004322.
  31. Redaktsiya, Slovar' terminov i sokrashchenii, ispol'zuemykh v dokazatel'noi meditsine. Dokazatel'naya kardiologiya (elektronnaya versiya). 2015;(8(1)):53-56.
  32. Alonso-Coello P, et al. Fiber for the treatment of hemorrhoids complications: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101(1):181-188.
  33. Garg P and Singh P. Adequate dietary fiber supplement and TONE can help avoid surgery in most patients with advanced hemorrhoids. Minerva Gastroenterol Dietol. 2017;63(2):92-96.
  34. Panpimanmas S, et al. Experimental comparative study of the efficacy and side effects of Cissus quadrangularis L. (Vitaceae) to Daflon (Servier) and placebo in the treatment of acute hemorrhoids. J Med Assoc Thai. 2010;93(12):1360-1367.
  35. De Almeida Cyrino FZG, et al. Effects of venotonic drugs on the microcirculation: Comparison between Ruscus extract and micronized diosmine1. Clin Hemorheol Microcirc. 2018;68(4):371-382.
  36. Giannini I, et al. Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial. Tech Coloproctol. 2015;19(6):339-345.
  37. Corsale I, et al. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I—III degree hemorroidal disease: a double-blind multicenter prospective comparative study. Int J Colorectal Dis; 2018.
  38. Trompetto M, et al. Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement. Tech Coloproctol. 2015;19(10):567-575.
  39. Yamana T. Japanese Practice Guidelines for Anal Disorders I. Hemorrhoids. Journal of the Anus, Rectum and Colon. 2017;1(3):89-99.
  40. Agarwal N, et al. Executive Summary — The Association of Colon & Rectal Surgeons of India (ACRSI) Practice Guidelines for the Management of Haemorrhoids-2016. Indian J Surg. 2017;79(1):58-61.
  41. Aggrawal K, et al. Efficacy of a standardized herbal preparation (Roidosanal((R))) in the treatment of hemorrhoids: A randomized, controlled, open-label multicentre study. J Ayurveda Integr Med. 2014;5(2):117-124.
  42. Higuero T, et al. Guidelines for the treatment of hemorrhoids (short report). J Visc Surg. 2016;153(3):213-218.
  43. Cyrino Fátima ZGA, et al. Micronization enhances the protective effect of purified flavonoid fraction against postischaemic microvascular injury in the hamster cheek pouch. Clinical and Experimental Pharmacology and Physiology. 2004;31(3):159-162.
  44. Manthey JA. Biological properties of flavonoids pertaining to inflammation. Microcirculation. 2000;7(6 Pt 2):S29-34.
  45. Mastantuono T, et al. Effects of Citrus Flavonoids Against Microvascular Damage Induced by Hypoperfusion and Reperfusion in Rat Pial Circulation. Microcirculation. 2015;22(5):378-390.
  46. Arango D, et al. Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets. Proc Natl Acad Sci USA. 2013;110(24):E2153-E2162.
  47. Fulton GP, Jackson RG and Lutz BR. Cinephotomicroscopy of normal blood circulation in the cheek pouch of the hamster. Anat Rec. 1946;96(4):537.
  48. Duling BR. The preparation and use of the hamster cheek pouch for studies of the microcirculation. Microvascular Research. 1973;5(3):423-429.
  49. Bertuglia S, Marchiafava PL and Colantuoni A. Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res. 1996;31(6):947-952.
  50. Bertuglia S, Colantuoni A and Intaglietta M. Capillary reperfusion after L-arginine, L-NMMA, and L-NNA treatment in cheek pouch microvasculature. Microvasc Res. 1995;50(2):162-174.
  51. Colantuoni A, et al. Protective effects of insulin during ischemia-reperfusion injury in hamster cheek pouch microcirculation. J Vasc Res. 2005;42(1):55-66.
  52. Bertuglia S, Giusti A and Del Soldato P. Antioxidant activity of nitro derivative of aspirin against ischemia-reperfusion in hamster cheek pouch microcirculation. Am J Physiol Gastrointest Liver Physiol. 2004;286(3):G437-443.
  53. Feletou M, Bonnardel E and Canet E. Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide. Br J Pharmacol. 1996;118(6):1371-1376.
  54. Guttadauro A, et al. Evolution in the surgical management of hemorrhoidal disease. Ann Ital Chir. 2018;89:101-106.
  55. Kaidar-Person O, Person B and Wexner SD. Hemorrhoidal disease: A comprehensive review. J Am Coll Surg. 2007;204(1):102-117.
  56. Thulesius O and Gjores JE. Arterio-venous anastomoses in the anal region with reference to the pathogenesis and treatment of haemorrhoids. Acta Chir Scand. 1973;139(5):476-478.
  57. Sanchez C and Chinn BT. Hemorrhoids. Clin Colon Rectal Surg. 2011;24(1):5-13.
  58. Kirienko A, Radak D. Clinical acceptability study of once-daily versus twice-daily micronized purified flavonoid fraction in patients with symptomatic chronic venous disease: a randomized controlled trial. International Angiology. 2016;35(4):399-405.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.